In glioma, siRNA-mediated FKBP51 knockdown alters cancer cell proliferation and enhances apoptosis, highlighting its tumor-suppressive effects (D’Arrigo et al., 2017, 2019; Pei et al., 2009; Yang et al., 2015). Here, FKBP5 is linked to cancer.